Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO19142-D1

Biomarker Field of development:

Gram-Negative Bacterial Infections Therapy Area:

Method Type of patent:

Method for diagnosing brucella infection

Brucella is a facultative intracellular pathogenic bacterium responsible for brucellosis, a worldwide re-emerging zoonotic disease affecting wildlife […]

BIO15218-D1

Biomarker Field of development:

Gram-Negative Bacterial Infections Therapy Area:

Biomarker Type of patent:

Methods and kits for the rapid detection of the escherichia coli

Escherichia coli O25b-ST131 clone is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. A high […]

BIO10913-D1

Biomarker Field of development:

Gram-Negative Bacterial Infections Therapy Area:

Method Type of patent:

Supercarba selective medium for the detection of carbapenem-resistant

Carbapenemase-producing bacteria isolates are increasingly identified throughout the world. Their early detection is becoming a major issue in the […]

147

56

310

46

Our Technology Offers

Method for diagnosing brucella infection

Methods and kits for the rapid detection of the escherichia coli

Supercarba selective medium for the detection of carbapenem-resistant

You might also be interested in

Mkpatentcrmfinalmarket

Testsynchrotheracrm1904

Cd38 as a biomarker and biotarget in

Methods of enhancing the potency of incretin-based

Apelin analogs for the treatment of heart failure

Monoacylglycerol lipase as target for the

Treatment of bone mineral density related diseases

Methods and compositions for treating skin

Use of coumarin derivatives for the preparation of

Methods and compositions for treating cell

Ctip fusion to cas9 enhances transgene integration

In vitro tests allowing to identify the potential